Subcutaneous APL-2: Phase I data

Data from a pair of double-blind, placebo-controlled, Australian Phase I trials in a

Read the full 136 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE